How many drugs treat coronary artery disease?

Drug Landscape tracks 4 marketed treatments for coronary artery disease (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/coronary-artery-disease.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

coronary artery disease — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

coronary artery disease (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating coronary artery disease, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	First approval
Flyrcado	FLURPIRIDAZ	Ge Hlthcare	Radioactive Diagnostic Agent [EPC]	2024-01-01
Fludeoxyglucose F-18	FLUDEOXYGLUCOSE	Downstate Clincl	Radioactive Diagnostic Agent [EPC]	2020-01-01
Fludeoxyglucose F-18	F-18	3D Imaging Drug	Radioactive Diagnostic Agent [EPC]	2015-01-01
Technetium Tc 99M Sestamibi	TECHNETIUM	Cyclomedica	Radioactive Diagnostic Agent [EPC]	1981-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

3D Imaging Drug · 1 drug in coronary artery disease
Cyclomedica · 1 drug in coronary artery disease
Downstate Clincl · 1 drug in coronary artery disease
Ge Hlthcare · 1 drug in coronary artery disease

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in coronary artery disease:

Cite this brief

Drug Landscape (2026). coronary artery disease — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/coronary-artery-disease. Accessed 2026-06-10.

coronary artery disease full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing